Bora Pharmaceuticals

Bora Pharmaceuticals https://validator.w3.org/feed/docs/rss2.html Test 財報與季度營運報告 Shareholder Services Leadership Board of Directors Reports and Presentations Bora Company Presentation at 43rd Annual J.P. Morgan Healthcare Conference Bora Health Partners with National Taiwan University Hospital andPatient Groups to Raise Awareness on World Parkinson’s Day Bora Wins Prestigious CDMO Leadership Awards Media Kit 投資人專區總覽水資源管理風險管理重要內規 Bora Appoints J.D. Mowery As First Division President Of Its CDMO Business Internal Policies 董事會領導團隊 Functional Committee 功能性委員會首頁 Consumer Healthcare 股東服務 IR Desk New Drug Research and Development 青年人才培育計畫人才培育與發展 Sustainability 消費性保健產品 Home 利害關係人專區保瑞宣布旗下第一個美國市場併購案收購美國百年知名藥廠Upsher-Smith、加速全球版圖擴張 Bio Korea 2024 2024 亞洲生技大展 2024 CPHI Milan 泰福生技完成合併保瑞生技台灣最大國際級CDMO戰隊正式成軍攜手強攻全球生物製劑代工市場開啟成長新篇章 12th Annual Top 10 Potential Business Gold Torch Award 2018 Taiwan MAPECT Taiwan M&A Awards Best Companies to Work for in Taiwan 2019 Awards CEO Bobby Sheng wins CEO of the Year at CPhI Awards 2020 Bora Pharmaceuticals is Awarded Outstanding Company of the Year at Bio-Asia Taiwan 2023 KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to manufacture generic product for filing in Japan 保瑞藥業與共和藥品工業株式會社(Kyowa)簽訂委託生產合作案 Bora Pharmaceuticals collaborates with Taishin Holdings to launch CDMO investment and M&A plan Bora Pharmaceuticals to expand operations with $10m investment Bora Pharmaceuticals acquires Eden Biologics CDMO Assets Bora establishes a leadership position in Taiwan’s CDMO sector as it continues to expand into the global CDMO market 保瑞藥業與韓國賽特瑞恩(CELLTRION) 簽訂委託生產合作案 Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market 大開「眼」界又一樁，保瑞跨足眼部用藥委託製造服務 Bora Pharmaceuticals unveils eye-opening new facility for Ophthalmic manufacturing